New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 28, 2012
10:47 EDTIRWDIronwood, Almirall say Constella approved in Europe for treatment of IBS-C
Almirall and Ironwood Pharmaceuticals announced that the European Commission has granted marketing authorization to Constella for the symptomatic treatment of moderate to severe Irritable Bowel Syndrome with Constipation, or IBS-C, in adults. This approval follows the positive recommendation received from the European Committee for Medicinal Products for Human Use in September.
News For IRWD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 9, 2014
08:02 EDTIRWDIronwood initiates Phase IIa study of IW-9179 in diabetic gastroparesis
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use